Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.62 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | F3 | P13726 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.46 |
| ▸ | RELA | Q04206 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15363576 | 1.00 | KMT2A (0.62) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL15364313 | 1.00 | KMT2A (0.62) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL30775463 | 1.00 | KMT2A (0.62) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL15364345 | 1.00 | KMT2A (0.62) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL15364341 | 1.00 | KMT2A (0.62) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL16024181 | 0.92 | KMT2A (0.55) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL27758582 | 0.92 | KMT2A (0.54) | KMT2AMAPTMEN1CYP19A1RAB9A | |
| SCHEMBL16024193 | 0.92 | KMT2A (0.55) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL21515007 | 0.92 | CYP19A1 (0.65) | KMT2AMAPTMEN1CYP19A1KDM4E | |
| SCHEMBL27737751 | 0.92 | KMT2A (0.54) | KMT2AMAPTMEN1CYP19A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117348297-A | Method for producing liquid crystal alignment film, method for producing liquid crystal display element, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2024-01-05 | — | — | CN | disclosed |
| US-20100060834-A1 | COPOLYIMIDE, LIQUID CRYSTAL ALIGNING LAYER COMPRISING THE SAME , AND LIQUID CRYSTAL DISPLAY COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2010-03-11 | — | — | US | disclosed |
| WO-2008084944-A1 | NEW COPOLYIMIDE, LIQUID CRYSTAL ALIGNING LAYER COMPRISING THE SAME, AND LIQUID CRYSTAL DISPLAY COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2008-07-17 | — | — | WO | disclosed |
| WO-2007064160-A1 | METHOD OF PRODUCING LIQUID CRYSTAL ALIGNING LAYER, LIQUID CRYSTAL ALIGNING LAYER PRODUCED USING THE SAME, AND LIQUID CRYSTAL DISPLAY INCLUDING LIQUID CRYSTAL ALIGNING LAYER | LG CHEM. LTD. (KR) | 2007-06-07 | — | — | WO | disclosed |
| US-20070128378-A1 | Method of producing liquid crystal aligning layer, liquid crystal aligning layer produced using the same, and liquid crystal display including liquid crystal aligning layer | LG CHEM, LTD. (KR) | 2007-06-07 | — | — | US | disclosed |
| US-6689899-B2 | HYDROGENATION OF THE CORRESPONDING DINITRO COMPOUNDS | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-02-10 | — | — | US | disclosed |
| US-6642393-B2 | Such as 2,5-(dihydroxybenzenecarboxylic octane)-dibenzoate-3,3',4,4' -tetracarboxylic acid anhydride for producing polyimides or polyamic acides having low water absorption; for use in cosmetics, aeronautics, and electronics | KANEKA CORPORATION (JP) | 2003-11-04 | — | — | US | disclosed |
| US-20020055610-A1 | Novel polyimide compositions and novel acid dianhydrides to be used therein | KANEKA CORPORATION (JP) | 2002-05-09 | — | — | US | disclosed |
| US-6350845-B1 | POLYAMIDEIMIDE COPOLYMERS FOR NONABSORBENT HEAT RESISTANT COMPOSITIONS | KANEKA CORPORATION (JP) | 2002-02-26 | — | — | US | disclosed |
| US-20020019558-A1 | Diamine and acid anhydride | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2002-02-14 | — | — | US | disclosed |
| US-6303742-B1 | CHARACTERIZED BY A CINNAMOYL GROUP OR A DERIVED CINNAMOYL GROUP INCORPORATED THEREIN AND BY PHOTO-REACTIVITY AND HEAT-REACTIVITY WHICH ARE INHERENT IN THE CINNAMOYL GROUP. | KANEKAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2001-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019558-A1 | Diamine and acid anhydride | CA1, ASIC1, CA4 | KMT2A 679/4885MAPT 573/4885MEN1 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.